Baxter International Inc (BAX) is scheduled to report 3rd quarter earnings on 11/02/2023, before the market opens.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Regarding Q3 estimates, Wall Street analysts expect Baxter International Inc to post earnings of $0.67 per share. Revenue expectations are pegged at $3.7 billion. Last quarter, Baxter International Inc missed earnings estimates, reporting EPS of $0.55 on estimates of $0.60. The stock fell by -7.10% the day after the last earnings release.
Year-to-date, BAX stock has fallen by -35.79%.
Is Baxter International Inc Stock a Buy?
Wall Street’s consensus rating for BAX stock is a Hold, with an average analyst price target of $42.50, implying upside potential of 32.65% from current levels.
BAX shares have lost about -31.84% in the past six months.
About Baxter International Inc
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
Stay up-to-date on earnings this week, with TipRanks’ Earnings Calendar.